Capricor Therapeutics (CAPR) Net Margin Growth (1y) (2012 - 2024)
Capricor Therapeutics (CAPR) Net Margin Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn | 447.00 |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | 2,072.00 |
| 10 | Capricor Therapeutics | 392.28 Mn | 392.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5,373.00 |
| Sep 30, 2024 | -562,308.00 |
| Jun 30, 2024 | -8,564.00 |
| Mar 31, 2024 | -13,678.00 |
| Dec 31, 2023 | 75,763.00 |
| Sep 30, 2023 | 135,129.00 |
| Jun 30, 2021 | 1.88 Mn |
| Mar 31, 2021 | -1.15 Mn |
| Dec 31, 2020 | -656,741.00 |
| Sep 30, 2020 | -6.99 Mn |
| Jun 30, 2020 | -2.08 Mn |
| Mar 31, 2020 | 13,947.00 |
| Dec 31, 2019 | -15,860.00 |
| Sep 30, 2019 | 67,564.00 |
| Jun 30, 2019 | 52,741.00 |
| Mar 31, 2019 | -31,384.00 |
| Dec 31, 2018 | 18,582.00 |
| Sep 30, 2018 | -101,346.00 |
| Jun 30, 2018 | 7,871.00 |
| Mar 31, 2018 | -57,814.00 |